The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients
Abstract
Background Between 1986 and 1998, eight cases of community-acquired pneumonia due to Staphylococcus aureus strains carrying the gene for the Panton-Valentine leukocidin (PVL) were recorded in France, six of which were fatal. We aimed to assess the clinical features of these eight cases, and those of other cases identified prospectively, and to compare them with the characteristics of patients with pneumonia caused by PVL-negative strains.Methods We compared eight retrospective and eight prospective cases of PVL-positive S aureus pneumonia with 36 cases of PVL-negative S aureus pneumonia. For all patients, we recorded age, length of hospital stay, risk factors for infection, signs and symptoms, laboratory findings, antibiotic treatment, and serial radiological findings.Findings Median age was 14.8 years (IQR 5.4-24.0) for the PVL-positive patients and 70.1 years (59.2-81.4) for the others (p=0.001). Influenza-like illness had occurred during the 2 days before admission in 12 of the 16 PVL-positive patients, but in only three of 33 PVL-negative patients (p<0.001). PVL-positive infections were more often marked by: temperature greater than 39 degrees C (p=0.01), heart rate above 140 beats per min (p=0.02), haemoptysis (p=0.005), onset of pleural effusion during hospital stay (p=0.004), and leucopenia (p=0.001). The survival rate 48 h after admission was 63% for the PVL-positive patients and 94% for PVL-negative individuals (p=0.007). Histopathological examination of lungs at necropsy from three cases of necrotising pneumonia associated with PVL-positive S aureus showed extensive necrotic ulcerations of the tracheal and bronchial mucosa and massive haemorrhagic necrosis of interalveolar septa.Interpretation PVL-producing S aureus strains cause rapidly progressive, haemorrhagic, necrotising pneumonia, mainly in otherwise healthy children and young adults. The pneumonia is often preceded by influenza-like symptoms and has a high lethality rate.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the recently emerged USA300 and USA400 clones that have been linked to a surge in necrotizing pneumonia in patients with influenza [9-11, 15, 29-31] act synergistically with influenza virus.”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [30]
In the citing paper
“which has been proposed as a marker for the enhanced virulence of USA300 and USA400 clones, particularly when their ability to cause necrotizing pneumonia in humans has been considered [30,31].”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [30]
In the citing paper
“Influenza-staphylococcal coinfections have increased following the emergence of the USA300 and USA400 lineages [9,11,30,31], and S. aureus has been identified as a common cause of death during the recent H1N1 influenza pandemic [12,15].”
From Influenza virus primes mice for pneumonia from Staphylococcus aureus. (2011) · cites this paper as [30]
Citations
Cites
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489
Self-citationNosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, N. N. I. S. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501795 · Cited by 1,028
Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction
Murakami, K., Minamide, W., Wada, K., Nakamura, E., Teraoka, H., & Watanabe, S. (1991) · Journal of Clinical Microbiology · doi:10.1128/jcm.29.10.2240-2244.1991 · Cited by 951
The staphylococci in human disease
Crossley, K., & Archer, G. L. (1996) · Churchill Livingstone eBooks · Cited by 625
Prévost, G., Cribier, B. J., Couppié, P., Petiau, P., Supersac, G., Finck‐Barbançon, V., Monteil, H., & Piémont, Y. (1995) · Infection and Immunity · doi:10.1128/iai.63.10.4121-4129.1995 · Cited by 299
Self-citationEpidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins
Prevost, G., Couppie, P., Prevost, P., Gayet, S., Petiau, P., Cribier, B., Monteil, H., & Piemont, Y. (1995) · Journal of Medical Microbiology · doi:10.1099/00222615-42-4-237 · Cited by 269
Self-citationSchwarzmann, S. W. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.1971.00310180053006 · Cited by 238
Plotkowski, M.-C., Puchelle, E., Beck, G., Jacquot, J., & Hannoun, C. (1986) · American Review of Respiratory Disease · doi:10.1164/arrd.1986.134.5.1040 · Cited by 231
Kaneko, J., Kimura, T., Narita, S., Tomita, N., & Kamio, Y. (1998) · Gene · doi:10.1016/s0378-1119(98)00278-9 · Cited by 231
Cited by
Sorted by citations
Tong, S. Y. C., Davis, J. S., Eichenberger, E., Holland, T. L., & Fowler, V. G. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00134-14 · Cited by 5,192
Waves of resistance: Staphylococcus aureus in the antibiotic era
Chambers, H. F., & DeLeo, F. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2200 · Cited by 2,718
Antibiotics and Bacterial Resistance in the 21st Century
Fair, R. J., & Tor, Y. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s14459 · Cited by 2,041
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Vandenesch, F., Naimi, T. S., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M. E., et al. (2003) · Emerging infectious diseases · doi:10.3201/eid0908.030089 · Cited by 1,718
Self-citationMethicillin-Resistant Staphylococcus aureus: Molecular Characterization, Evolution, and Epidemiology
Lakhundi, S., & Zhang, K. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00020-18 · Cited by 1,762
Naimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Diep, B. A., Gill, S. R., Chang, R. F., Phan, T. H., Chen, J. H., Davidson, M. G., Lin, F., Lin, J., Carleton, H. A., Mongodin, E. F., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68231-7 · Cited by 1,633
Community-associated meticillin-resistant Staphylococcus aureus
DeLeo, F. R., Otto, M. J., Kreiswirth, B. N., & Chambers, H. F. “. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61999-1 · Cited by 1,534
McDougal, L. K., Steward, C. D., Killgore, G., Chaitram, J. M., McAllister, S. K., & Tenover, F. C. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5113-5120.2003 · Cited by 1,410
Genome and virulence determinants of high virulence community-acquired MRSA
Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K.-I., Oguchi, A., Nagai, Y., Iwama, N., Asano, K., Naimi, T. S., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08713-5 · Cited by 1,356
Autoinduction and signal transduction in the regulation of staphylococcal virulence
Novick, R. P. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03526.x · Cited by 1,271
Immune evasion by staphylococci
Foster, T. J. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1289 · Cited by 1,214
Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat
Grundmann, H., Aires-de-Sousa, M., Boyce, J. M., & Tiemersma, E. W. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68853-3 · Cited by 1,096
Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A. S., Tang, A. W., Phung, T. O., & Spellberg, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042683 · Cited by 1,053
Wang, R., Braughton, K. R., Kretschmer, D., Bach, T.-H. L., Queck, S. Y., Li, M., Kennedy, A. D., Dorward, D. W., Klebanoff, S. J., Peschel, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1656 · Cited by 1,046
Quorum Sensing in Staphylococci
Novick, R. P., & Geisinger, E. (2008) · Annual Review of Genetics · doi:10.1146/annurev.genet.42.110807.091640 · Cited by 953
Guidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M. A., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M. M., Örtqvist, Å., Schaberg, T., Torres, A., van der Heijden, G. J. M. G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 949
Predictors of Mortality in Staphylococcus aureus Bacteremia
van Hal, S. J., Jensen, S. O., Vaska, V. L., Espedido, B. A., Paterson, D. L., & Gosbell, I. B. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05022-11 · Cited by 934
Epidemiology of Methicillin‐Resistant Staphylococcus aureus
Boucher, H. W., & Corey, G. R. (2008) · Clinical Infectious Diseases · doi:10.1086/533590 · Cited by 826
A meta-analysis of randomized controlled trials: Efficacy of selenium treatment for sepsis
Li, S., Tang, T., Guo, P., Zou, Q., Ao, X., Hu, L., & Tan, L. (2019) · Medicine · doi:10.1097/md.0000000000014733 · Cited by 802
Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat
Zetola, N., Francis, J. S., Nuermberger, E. L., & Bishai, W. R. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70112-2 · Cited by 791
The co-pathogenesis of influenza viruses with bacteria in the lung.
McCullers, J. A. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3231 · Cited by 722
The evolution of Staphylococcus aureus
Deurenberg, R. H., & Stobberingh, E. E. (2008) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2008.07.007 · Cited by 746
Francis, J. S., Doherty, M. C., Lopatin, U. A., Johnston, C. P., Sinha, G., Ross, T. L., Cai, M., Hansel, N. N., Perl, T. M., Ticehurst, J. R., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/427148 · Cited by 715
Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia
Labandeira‐Rey, M., Couzon, F., Boisset, S., Brown, E. L., Bes, M., Benito, Y., Barbu, E. M., Sarathy, V. V., Höök, M., Étienne, J., et al. (2007) · Science · doi:10.1126/science.1137165 · Cited by 707
Self-citationKöck, R., Becker, K., Cookson, B., van Gemert-Pijnen, J. E., Harbarth, S., Kluytmans, J., Mielke, M., Peters, G., Skov, R. L., Struelens, M. J., et al. (2010) · Eurosurveillance · doi:10.2807/ese.15.41.19688-en · Cited by 611
Three-Year Surveillance of Community-AcquiredStaphylococcus aureus Infections in Children
Kaplan, S. L., Hultén, K. G., Gonzalez, B. E., Hammerman, W. A., Lamberth, L. B., Versalovic, J. A., & Mason, E. O. (2005) · Clinical Infectious Diseases · doi:10.1086/430312 · Cited by 597
Queck, S. Y., Jameson‐Lee, M., Villaruz, A. E., Bach, T. L., Khan, B. A., Sturdevant, D. E., Ricklefs, S., Li, M., & Otto, M. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.005 · Cited by 597
Staphylococcal manipulation of host immune responses
Thammavongsa, V., Kim, H. K., Missiakas, D. M., & Schneewind, O. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3521 · Cited by 618
Staphylococcus aureusCapsular Polysaccharides
O'Riordan, K., & Lee, J. C. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.1.218-234.2004 · Cited by 582
Mobile genetic elements of Staphylococcus aureus
Małachowa, N., & DeLeo, F. R. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0389-4 · Cited by 566
Insights into Mechanisms Used by Staphylococcus aureus to Avoid Destruction by Human Neutrophils
Voyich, J. M., Braughton, K. R., Sturdevant, D. E., Whitney, A. R., Saïd-Salim, B., Porcella, S. F., Long, R. D., Dorward, D. W., Gardner, D. J., Kreiswirth, B. N., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.6.3907 · Cited by 563
Voyich, J. M., Otto, M. J., Mathema, B., Braughton, K. R., Whitney, A. R., Welty, D. M., Long, R. D., Dorward, D. W., Gardner, D. J., Lina, G., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/509506 · Cited by 562
Self-citationBoyle‐Vavra, S., & Daum, R. S. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700501 · Cited by 548
Tenover, F. C., McDougal, L. K., Goering, R. V., Killgore, G., Projan, S. J., Patel, J. B., & Dunman, P. M. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.1.108-118.2006 · Cited by 524
Dufour, P., Gillet, Y., Bes, M., Lina, G., Vandenesch, F., Floret, D., Étienne, J., & Richet, H. (2002) · Clinical Infectious Diseases · doi:10.1086/342576 · Cited by 509
Self-citationReemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
DeLeo, F. R., & Chambers, H. F. “. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38226 · Cited by 522
Frazee, B. W., Lynn, J., Charlebois, E. D., Lambert, L., Lowery, D., & Perdreau-Remington, F. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.10.011 · Cited by 494
Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases
de Oliveira, D. M., Borges, A. D. S., & Simões, M. V. (2018) · Toxins · doi:10.3390/toxins10060252 · Cited by 533
Poring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia
Bubeck Wardenburg, J., Bae, T., Otto, M., DeLeo, F. R., & Schneewind, O. (2007) · Nature Medicine · doi:10.1038/nm1207-1405 · Cited by 492
Guidelines for the management of adult lower respiratory tract infections - Summary
Woodhead, M. A., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M. M., Örtqvist, Å., Schaberg, T., Torres, A., van der Heijden, G. J. M. G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03602.x · Cited by 473
Methicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic Odyssey
Deresinski, S. C. (2005) · Clinical Infectious Diseases · doi:10.1086/427701 · Cited by 465
Staphylococcus aureus : superbug, super genome?
Lindsay, J. A., & Holden, M. T. G. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2004.06.004 · Cited by 479
Basis of Virulence in Community-Associated Methicillin-Resistant Staphylococcus aureus
Otto, M. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134309 · Cited by 457
Ellis, M. W., Hospenthal, D. R., Dooley, D. P., Gray, P. J., & Murray, C. K. (2004) · Clinical Infectious Diseases · doi:10.1086/423965 · Cited by 446
Löffler, B., Hussain, M., Grundmeier, M., Brück, M., Holzinger, D., Varga, G., Roth, J., Kahl, B. C., Proctor, R. A., & Peters, G. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000715 · Cited by 457
Community-Associated MRSA — Resistance and Virulence Converge
Chambers, H. F. “. (2005) · New England Journal of Medicine · doi:10.1056/nejme058023 · Cited by 422
Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC
Ito, T., Okuma, K., Xue, X., Yuzawa, H., & Hiramatsu, K. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00003-7 · Cited by 417
Skin and Soft-Tissue Infections Caused by Methicillin-ResistantStaphylococcus aureus
Daum, R. S. (2007) · New England Journal of Medicine · doi:10.1056/nejmcp070747 · Cited by 420
Genestier, A.-L., Michallet, M.-C., Prévost, G., Bellot, G., Chalabreysse, L., Peyrol, S., Thivolet, F., Etienne, J., Lina, G., Vallette, F. M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22684 · Cited by 416
Self-citationMartínez‐Aguilar, G., Mishaan, A. M. A., Hultén, K. G., Hammerman, W. A., Mason, E. O., & Kaplan, S. L. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000133044.79130.2a · Cited by 413
McClure, J., Conly, J. M., Lau, V., Elsayed, S., Louie, T., Hutchins, W., & Zhang, K. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.3.1141-1144.2006 · Cited by 412
Vaccine protection against Staphylococcus aureus pneumonia
Wardenburg, J. B., & Schneewind, O. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072208 · Cited by 406
Staphylococcus aureus Toxins: An Update on Their Pathogenic Properties and Potential Treatments
Ahmad-Mansour, N., Loubet, P., Pouget, C., Dunyach‐Remy, C., Sotto, A., Lavigne, J., & Molle, V. (2021) · Toxins · doi:10.3390/toxins13100677 · Cited by 429
Vandenesch, F., Lina, G., & Henry, T. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00012 · Cited by 405
Self-citationTristan, A., Bes, M., Meugnier, H., Lina, G., Bozdoğan, B., Courvalin, P. M., Reverdy, M. E., Enright, M. C., Vandenesch, F., & Étienne, J. (2007) · Emerging infectious diseases · doi:10.3201/eid1304.061316 · Cited by 412
Self-citationRole of Pore-Forming Toxins in Bacterial Infectious Diseases
Los, F. C. O., Randis, T. M., Aroian, R. V., & Ratner, A. J. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00052-12 · Cited by 421
Neutrophils in innate host defense against Staphylococcus aureus infections
Rigby, K. M., & DeLeo, F. R. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-011-0295-3 · Cited by 400
Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe
Otter, J. A., & French, G. L. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70053-0 · Cited by 413
Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus
Li, M., Diep, B. A., Villaruz, A. E., Braughton, K. R., Jiang, X., DeLeo, F. R., Chambers, H. F., Lu, Y., & Otto, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900743106 · Cited by 394
Natural products to drugs: daptomycin and related lipopeptide antibiotics
Baltz, R. H., Miao, V., & Wrigley, S. K. (2005) · Natural Product Reports · doi:10.1039/b416648p · Cited by 393
The phage-related chromosomal islands of Gram-positive bacteria
Novick, R. P., Christie, G. E., & Penadés, J. R. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2393 · Cited by 390
Gonzalez, B. E., Martínez‐Aguilar, G., Hultén, K. G., Hammerman, W. A., Coss‐Bu, J. A., Avalos-Mishaan, A., Mason, E. O., & Kaplan, S. L. (2005) · PEDIATRICS · doi:10.1542/peds.2004-2300 · Cited by 385
Holmes, A., Ganner, M., McGuane, S., Pitt, T. L., Cookson, B., & Kearns, A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.5.2384-2390.2005 · Cited by 380
Saiman, L., Keefe, M. O., Graham, P. L., Wu, F., Salim, B. S., Kreiswirth, B., LaSala, A., Schlievert, P. M., & Latta, P. D. (2003) · Clinical Infectious Diseases · doi:10.1086/379022 · Cited by 372
Bocchini, C. E., Hultén, K. G., Mason, E. O., Gonzalez, B. E., Hammerman, W. A., & Kaplan, S. L. (2006) · PEDIATRICS · doi:10.1542/peds.2005-0566 · Cited by 366
Complicated pneumonia in children
Benedictis, F. M. D., Kerem, E., Chang, A. B., Colin, A. A., Zar, H. J., & Bush, A. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31550-6 · Cited by 370
Changing Patterns of Acute Hematogenous Osteomyelitis and Septic Arthritis
Arnold, S. R., Elias, D. B., Buckingham, S. C., Thomas, E. D., Novais, E. N. V., Arkader, A., & Howard, C. (2006) · Journal of Pediatric Orthopaedics · doi:10.1097/01.bpo.0000242431.91489.b4 · Cited by 356
Surface Proteins and Exotoxins Are Required for the Pathogenesis of Staphylococcus aureus Pneumonia
Wardenburg, J. B., Patel, R. J., & Schneewind, O. (2007) · Infection and Immunity · doi:10.1128/iai.01313-06 · Cited by 348
Diep, B. A., Chan, L., Tattevin, P., Kajikawa, O., Martin, T. R., Basuino, L., Mai, T. T., Marbach, H., Braughton, K. R., Whitney, A. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912403107 · Cited by 347
Self-citationThe Staphylococcus aureus “superbug”
Foster, T. J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci23825 · Cited by 355
Gillet, Y., Vanhems, P., Lina, G., Bes, M., Vandenesch, F., Floret, D., & Etienne, J. (2007) · Clinical Infectious Diseases · doi:10.1086/519263 · Cited by 340
Self-citationMethicillin-Resistant Staphylococcus aureus: An Evolving Pathogen
Stryjewski, M. E., & Corey, G. R. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit613 · Cited by 334
The role of virulence determinants in community-associated MRSA pathogenesis
Diep, B. A., & Otto, M. J. (2008) · Trends in Microbiology · doi:10.1016/j.tim.2008.05.002 · Cited by 335
Burts, M. L., Williams, W. A., DeBord, K. L., & Missiakas, D. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405620102 · Cited by 345
Martínez‐Aguilar, G., Hammerman, W. A., Mason, E. O., & Kaplan, S. L. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000073163.37519.ee · Cited by 314
Pneumonia Caused by Methicillin‐Resistant Staphylococcus aureus
Rubinstein, E., Kollef, M. H., & Nathwani, D. (2008) · Clinical Infectious Diseases · doi:10.1086/533594 · Cited by 313
Staphylococcus aureus virulence genes identified by bursa aurealis mutagenesis and nematode killing
Bae, T., Banger, A. K., Wallace, A., Glass, E. M., Åslund, F., Schneewind, O., & Missiakas, D. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404728101 · Cited by 322
Diep, B. A., Carleton, H. A., Chang, R. F., Sensabaugh, G. F., & Perdreau‐Remington, F. (2006) · The Journal of Infectious Diseases · doi:10.1086/503777 · Cited by 311
Vaccine assembly from surface proteins of Staphylococcus aureus
Stranger-Jones, Y. K., Bae, T., & Schneewind, O. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606863103 · Cited by 309
Cao, B., Huang, Y. X., She, D., Cheng, Q., Fan, H. S., Tian, X., Xu, J., Zhang, J., Chen, Y., Shen, N., et al. (2017) · The Clinical Respiratory Journal · doi:10.1111/crj.12674 · Cited by 309
The Staphylococcal Toxin Panton-Valentine Leukocidin Targets Human C5a Receptors
Spaan, A. N., Henry, T., van Rooijen, W. J. M., Perret, M., Badiou, C., Aerts, P. C., Kemmink, J., de Haas, C. J. C., van Kessel, K. P. M., Vandenesch, F., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.04.006 · Cited by 313
Self-citationGould, I. M., David, M. Z., Esposito, S., Garau, J., Lina, G., Mazzei, T., & Peters, G. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.09.028 · Cited by 303
Self-citationGonzalez, B. E., Hultén, K. G., Dishop, M. K., Lamberth, L. B., Hammerman, W. A., Mason, E. O., & Kaplan, S. L. (2005) · Clinical Infectious Diseases · doi:10.1086/432475 · Cited by 283
Hwang, J. H., Lyes, M., Sladewski, K. M., Enany, S., McEachern, E. K., Mathew, D. P., Das, S., Moshensky, A., Bapat, S. P., Pride, D. T., et al. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1378-3 · Cited by 280
Staphylococcus aureusSepsis and the Waterhouse–Friderichsen Syndrome in Children
Adem, P. V., Montgomery, C. P., Husain, A. N., Koogler, T. K., Arangelovich, V., Humilier, M., Boyle‐Vavra, S., & Daum, R. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044194 · Cited by 277
The Bicomponent Pore-Forming Leucocidins of Staphylococcus aureus
Alonzo, F., & Torres, V. J. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00055-13 · Cited by 292
Boyle‐Vavra, S., Ereshefsky, B., Wang, C., & Daum, R. S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4719-4730.2005 · Cited by 275
Host defense and pathogenesis in Staphylococcus aureus infections
DeLeo, F. R., Diep, B. A., & Otto, M. (2009) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2008.10.003 · Cited by 269
“the PVL genes (lukS-PV and lukF-PV, abbreviated as lukS/F-PV) and fatal necrotizing pneumonia renewed and intensified interest in understanding the biological role of this bicomponent cytolytic toxin.(83) Epidemiologic data alone, however, are insufficient to establish whether PVL directly contributes to widespread di…”
BackgroundModulation of phagocyte apoptosis by bacterial pathogens
DeLeo, F. R. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000031448.64969.fa · Cited by 265
Fowler, V. G., Justice, A., Moore, C. E., Benjamin, D. K., Woods, C. W., Campbell, S., Reller, L. B., Corey, G. R., Day, N., & Peacock, S. J. (2005) · Clinical Infectious Diseases · doi:10.1086/427806 · Cited by 261
Diep, B. A., Sensabaugh, G. F., Somboona, N. S., Carleton, H. A., & Perdreau‐Remington, F. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.5.2080-2084.2004 · Cited by 254
Livestock-associated Staphylococcus aureus
Fluit, A. C. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03846.x · Cited by 252
Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus
Melles∗, D. C., Gorkink, R. F. J., Boelens, H. A. M., Snijders, S. V., Peeters, J. K., Moorhouse, M. J., van der Spek, P. J., van Leeuwen, W. B., Simons, G., Verbrugh, H. A., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci23083 · Cited by 254
Robinson, D. A., Kearns, A., Holmes, A. M., Morrison, D., Grundmann, H., Edwards, G. F., O’Brien, F. G., Tenover, F. C., McDougal, L. K., Monk, A. B., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)74814-5 · Cited by 252
Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus
vanBelkum, A. F., Melles∗, D. C., Nouwen, J. L., vanLeeuwen, W. B., van Wamel, W. J. B., Vos, M. D., Wertheim, H. F. L., & Verbrugh, H. A. (2008) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2008.09.012 · Cited by 261
Serious Infections Caused by Methicillin‐Resistant Staphylococcus aureus
Boucher, H. W., Miller, L. G., & Razonable, R. R. (2010) · Clinical Infectious Diseases · doi:10.1086/653519 · Cited by 252
Sortase as a Target of Anti-Infective Therapy
Maresso, A. W., & Schneewind, O. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07110 · Cited by 254
Community‐Associated Methicillin‐ResistantStaphylococcus aureus
Weber, J. T. (2005) · Clinical Infectious Diseases · doi:10.1086/430788 · Cited by 246
Metadata
- Authors
- Gillet, Y., Issartel, B., Vanhems, P., Fournet, J.-C., Lina, G., Bes, M., Vandenesch, F., Piémont, Y., Brousse, N., Floret, D., & Etienne, J.
- Affiliations
- Hôpital Edouard Herriot (FR)
- Inserm (FR)
- Hôpital Necker-Enfants Malades (FR)
- Université de Strasbourg (FR)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2002-03
- Volume
- 359
- Issue
- 9308
- Pages
- 753-759
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2133530652
- Cited by
- 1,514
- References
- 38
- Citations by year
- 2026: 23 · 2025: 26 · 2024: 24 · 2023: 38 · 2022: 36 · 2021: 31 · 2020: 46 · 2019: 47 · 2018: 38 · 2017: 50 · 2016: 61 · 2015: 52 · 2014: 76 · 2013: 72 · 2012: 84
- FWCI
- 37.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Minnesota Department of Health
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Health Sciences › Medicine › Infectious Diseases › Streptococcal Infections and Treatments
- Keywords
- Staphylococcus aureus, Panton-Valentine leukocidin, necrotizing pneumonia, community-acquired pneumonia, children, influenza-like illness, hemorrhagic necrosis, pleural effusion, hemoptysis, leukopenia, mortality, virulence factors, clinical features
- MeSH terms
- Adolescent, Adult, Bacterial Toxins, Bronchi, Child, Child, Preschool, Exotoxins, Female, France, Humans, Leukocidins, Male, Necrosis, Pneumonia, Staphylococcal, Prospective Studies, Pulmonary Alveoli, Staphylococcus aureus, Trachea, Virulence, Community-Acquired Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review